EGFR and neoplasm: In a multivariate survival analysis adjusting for T stage, N stage, tumour grade, vascular invasion and age, EGFR overexpression was independently associated with worse survival time (P<0.001) (HR (95% CI)=1.93 (1.44–2.57)).